In other studies that utilized rats with diet-induced obesity, CB1 receptor expression in the kidney is notably upregulated, and treatment with a CB1 receptor antagonist reduced weight, systolic blood pressure, plasma leptin, albuminuria, and plasma creatinine levels. Here, LEP is linked to obesity disorder.